title: Rosiglitazone and cardiovascular risk.
authors.forename: Edoardo
authors.initials: E
authors.lastname: Mannucci
authors.forename: Matteo
authors.initials: M
authors.lastname: Monami
authors.forename: Niccolò
authors.initials: N
authors.lastname: Marchionni
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000401:mortality; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000139:chemically induced*; D012306:Risk; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*